Investigating the resistance mechanisms of nontransformed cells could provide insight into the role of INF2 in specific cancers and help explain the differential susceptibility of podocytes, Schwann cells, and sensory neurons, especially if the observed axonal loss is a direct effect. The gene discussed is INF2; the disease is cancer.